Barro, Christian et al "Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis." Neurology - Neuroimmunology Neuroinflammation 10.1 (2023): e200052. Web. 04 Feb. 2023.